The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

The US regulator issued a complete response letter (CRL) for the MedinCell-partnered drug, and the companies ... from its takeover of generics business Actavis. Since then, newer new drugs Austedo ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain ...

However the drug has faced generic competition from Actavis since 2013, with more generic versions being launched this year.

When a medication works right, it boosts your health or helps you feel better. But a drug can bring on problems if it doesn't mix well with something else you put into your body, like another ...

Instead, as Chief Justice Roberts predicted in his dissent (“Good luck to the district courts”), district courts have struggled to apply a clear (or consistent) analytical framework to cases brought ...

For branded drugmakers, the development of a pharmaceutical product approved by the Food and Drug Administration (FDA) all ...

5 This new and uncertain post-Actavis era led to numerous cases across the country in which plaintiffs challenged patent settlements for including allegedly unlawful reverse payments. Yet ...

The drug, which was developed in collaboration ... had north of $35 billion in net debt following its acquisition of Actavis in 2016, it now has less than $15.7 billion in net debt on its balance ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...